rs372169366
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_006231.4(POLE):c.6004+5G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,608,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006231.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.6004+5G>T | splice_region_variant, intron_variant | Intron 43 of 48 | ENST00000320574.10 | NP_006222.2 | ||
POLE | XM_011534795.4 | c.6004+5G>T | splice_region_variant, intron_variant | Intron 43 of 47 | XP_011533097.1 | |||
POLE | XM_011534797.4 | c.5083+5G>T | splice_region_variant, intron_variant | Intron 35 of 39 | XP_011533099.1 | |||
POLE | XM_011534802.4 | c.2992+5G>T | splice_region_variant, intron_variant | Intron 19 of 23 | XP_011533104.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000312 AC: 76AN: 243762Hom.: 0 AF XY: 0.000197 AC XY: 26AN XY: 131698
GnomAD4 exome AF: 0.000177 AC: 258AN: 1456000Hom.: 0 Cov.: 30 AF XY: 0.000169 AC XY: 122AN XY: 723868
GnomAD4 genome AF: 0.000131 AC: 20AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:2Benign:2
- -
- -
- -
The c.6004+5G>T variant in POLE has not been previously reported in individuals with colorectal cancer but has been identified in 22/65018 of European chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs372169366). This variant is located in the 5' splice region. Although nucl eotide substitutions at +5 position of the intron are relatively common causes o f aberrant splicing, computational tools do not suggest an impact to splicing. H owever, this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the c.6004+5G>T variant is uncertain. -
Hereditary cancer-predisposing syndrome Benign:3
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
- -
not provided Benign:2
- -
- -
Colorectal cancer, susceptibility to, 12 Uncertain:1
- -
POLE-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at